Catch up on the latest news, innovation and thought leadership from Roche Diagnostics.
Catch up on the latest news, innovation and thought leadership from Roche Diagnostics.
Medical Laboratory Observer
February 26, 2024
In the past 40 years, the number of cases and deaths from cervical cancer have decreased significantly as more women regularly had Pap tests and with the introduction of human papillomavirus (HPV) testing and the development of HPV vaccines.
Medical Laboratory Observer
February 26, 2024
Laboratories may begin to see an influx of cardiac biomarker tests accompanying HbA1c testing based on updated American Diabetes Association guidelines concerning heart failure in people with diabetes.
Medical Laboratory Observer
November 20, 2023
In the unpredictable post-COVID-19 pandemic era, patient expectations have shifted when it comes to diagnostic testing.
Medical Laboratory Observer
January 23, 2023
Since 2015, only about 1.2 million people have been considered ‘at risk’ of HIV and potentially able to benefit from pre-exposure prophylaxis, also known as PrEP, according to medical literature. These numbers were gleaned by focusing on identifiable populations, such as men who have sex with men and drug users who use needles.
Medical Laboratory Observer
September 21, 2022
Recent advances in treating breast cancer are reaching back to the past to the first known biomarker, human epidermal growth factor, to determine its value in treating patients with lower levels of HER2 expression and potentially open the door to new, targeted, and personalized therapies for many patients.
Medical Laboratory Observer
August 24, 2022
If respiratory diseases were not complicated enough before COVID-19, this fall may be the example of peak complexity as atypical infectious disease seasons threaten to become the new normal and COVID-19 continues to mutate.